News
BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19...
BioNTech SE announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in Marburg,...
News
Lilly announces proof of concept data for neutralizing antibody...
Eli Lilly and Company announced proof of concept data from an interim analysis of the BLAZE-1 clinical trial, showing a reduced rate of hospitalization for...
News
AstraZeneca acquires oral PCSK9 inhibitor programme from Dogma Therapeutics
AstraZeneca has entered into an agreement with Dogma Therapeutics to acquire its preclinical oral PCSK9 inhibitor programme. The Company aims to take the programme forward...
News
Univercells Technologies introduces the NevoLine Upstream Platform
Univercells Technologies is introducing the new generation of the NevoLine biomanufacturing product family, the NevoLine Upstream platform.
This high-performance, low-footprint upstream manufacturing platform is suitable for...
Clinical Trials
Sorrento Receives US FDA Clearance to Proceed With Phase...
Sorrento Therapeutics, Inc. announced that it received a study may proceed letter from the FDA for its phase 1 clinical trial for COVI-GUARD (STI-1499) in...
Drug Research
Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations
Seattle Genetics, Inc. and Merck, known as MSD outside the United States and Canada, announced two new strategic oncology collaborations.
The companies will globally develop and...
News
CPhI Annual Report 2020 Part 1: 2025 will see...
CPhI Annual Report – launched ahead of the first CPhI Festival of Pharma (5-16 October, 2020), the world’s largest digital pharma Expo – predicts dramatic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.